Related Experiment Video
Updated: Aug 11, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Role of epigenetic changes in hematological malignancies
Ulrich Lehmann1, Kai Brakensiek, Hans Kreipe
1Institute of Pathology, Medizinische Hochschule Hannover, Carl-Neuberg-Str.1, 30625, Hannover, Germany. Lehmann.Ulrich@MH-Hannover.de
Abstract:
Inactivation of tumor suppressor genes is an important event contributing to the development of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point mutations, growth regulatory genes can be functionally inactivated without alterations of the primary sequence by methylation of cytosine residues in the promoter regions of the genes. After introducing epigenetic phenomena in general and the molecular basis of DNA methylation in more detail, this review will present the broad spectrum of alterations in DNA methylation patterns found in hematopoietic malignancies. In addition, the implications for therapy and prognosis will be discussed.
Insights
Tumor suppressor gene inactivation, crucial in cancer, can occur via DNA methylation, an epigenetic change. This review explores DNA methylation alterations in blood cancers and their therapeutic and prognostic implications.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Inactivation of tumor suppressor genes is a key step in cancer development.
- Besides genetic mutations, epigenetic alterations like DNA methylation can silence these genes.
- DNA methylation involves adding a methyl group to cytosine residues in gene promoter regions.
Purpose of the Study:
- To review the role of epigenetic phenomena, specifically DNA methylation, in cancer.
- To detail the molecular mechanisms of DNA methylation.
- To examine DNA methylation patterns in hematopoietic malignancies and their clinical relevance.
Main Methods:
- Literature review of epigenetic phenomena and DNA methylation.
- Analysis of studies reporting DNA methylation patterns in blood cancers.
- Discussion of therapeutic and prognostic implications.
Main Results:
- DNA methylation is a significant mechanism for functional inactivation of tumor suppressor genes.
- Aberrant DNA methylation patterns are widespread in various hematopoietic malignancies.
- These epigenetic alterations have potential as biomarkers for prognosis and therapeutic targets.
Conclusions:
- Epigenetic dysregulation, particularly DNA methylation, is fundamental to the pathogenesis of blood cancers.
- Understanding these alterations offers new avenues for cancer therapy and predicting patient outcomes.
More Related Videos
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
Lineage Commitment
Regulation of Hematopoietic Stem Cells
Epigenetic Regulation
X-chromosome...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...

